Labcorp Holdings Inc.
321.10USD
-3.7600 (-1.16%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.65▲ | $4.59 | 10 | 0 |
| Next quarter | $4.45▲ | $4.39 | 10 | 0 |
| Current year | $18.35▲ | $18 | 15 | 0 |
| Next year | $19.82▲ | $19.44 | 17 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.77 | $4.99 | +0.22 (+4.6%) |
| 2026-03-31 | $4.12 | $4.25 | +0.13 (+3.3%) |
| 2025-12-31 | $3.94 | $4.07 | +0.13 (+3.2%) |
| 2025-09-30 | $4.14 | $4.18 | +0.04 (+1.0%) |
253 ratings from 33 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Neutral | $300 $309 | Aug 4, 2026 |
| JP Morgan | Maintained | Overweight | $330 $360 | Aug 3, 2026 |
| Morgan Stanley | Maintained | Overweight | $308 $338 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $320 $350 | Jul 31, 2026 |
| Barclays | Maintained | Equal-Weight | $290 $320 | Jul 31, 2026 |
| B of A Securities | Maintained | Buy | $300 $320 | Jul 13, 2026 |
| Baird | Maintained | Outperform | $335 $338 | Jul 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $280 $300 | Apr 8, 2026 |
| Piper Sandler | Maintained | Neutral | $270 $300 | Feb 24, 2026 |
| JP Morgan | Maintained | Overweight | $319 $330 | Feb 18, 2026 |
| Baird | Maintained | Outperform | $313 $326 | Feb 18, 2026 |
| JP Morgan | Maintained | Overweight | $317 $319 | Feb 6, 2026 |
| JP Morgan | Maintained | Overweight | $291 $317 | Nov 7, 2025 |
| UBS | Maintained | Buy | $325 $320 | Oct 29, 2025 |
| UBS | Maintained | Buy | $305 $325 | Oct 17, 2025 |
| Mizuho | Maintained | Outperform | $285 $320 | Oct 17, 2025 |
| Evercore ISI Group | Maintained | Outperform | $300 $305 | Oct 3, 2025 |
| Barclays | Maintained | Equal-Weight | $275 $290 | Oct 2, 2025 |
| Truist Securities | Maintained | Buy | $290 $310 | Jul 25, 2025 |
| UBS | Maintained | Buy | $282 $305 | Jul 25, 2025 |
| Evercore ISI Group | Maintained | Outperform | $285 $300 | Jul 25, 2025 |
| Morgan Stanley | Maintained | Overweight | $283 $306 | Jul 25, 2025 |
| Baird | Maintained | Outperform | $290 $302 | Jul 25, 2025 |
| UBS | Maintained | Buy | $284 $282 | Jul 18, 2025 |
| Evercore ISI Group | Maintained | Outperform | $260 $285 | Jul 9, 2025 |
146 filings from 28 insiders · 15 buy / 10 sell over 6m
Officers and directors of LH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Oyegunwa AkinboladeOfficer, EVP, CIO & CTO | GrantRestricted Stock Unit | 750 | — | — | Sep 1, 2026 |
| Meltzer Jonathan COfficer, EVP, COO | GrantRestricted Stock Unit | 900 | — | — | Sep 1, 2026 |
| Vaughn Bryan TOfficer, EVP and President, Diagnostics | GrantRestricted Stock Unit | 1.5k | — | — | Sep 1, 2026 |
| Caveney Brian JOfficer, EVP, Pres of BLS, CMO & CSO | GrantRestricted Stock Unit | 3.0k | — | — | Sep 1, 2026 |
| ANDERSON KERRII BDirector | Sell | 3.0k | $318.02 | $954k | Aug 17, 2026 |
| SCHECHTER ADAM HChief Executive Officer | Sell | 4.7k | $320.37 | $1.50M | Aug 11, 2026 |
| SUMMY AMY BOfficer | Sell | 924 | $306.74 | $283k | Aug 4, 2026 |
| WILKINSON PETER JOfficer | Exercise | 1.3k | $209.25 | $280k | Aug 3, 2026 |
| WILKINSON PETER JOfficer | Sell | 1.4k | $309.22 | $439k | Aug 3, 2026 |
| KYLE KATHRYN WOfficer | Sell | 92 | $286.19 | $26k | Jul 2, 2026 |
| VAUGHN BRYAN TOfficer | Sell | 234 | $286.19 | $67k | Jul 2, 2026 |
| KYLE KATHRYN WOfficer | Other | 256 | — | — | Jul 1, 2026 |
| VAUGHN BRYAN TOfficer | Other | 327 | — | — | Jul 1, 2026 |
| KYLE KATHRYN WOfficer | Sell | 762 | $263.89 | $201k | Jun 8, 2026 |
| SCHECHTER ADAM HChief Executive Officer | Sell | 5.9k | $254.50 | $1.50M | May 11, 2026 |
| MELTZER JONATHAN COfficer | Sell | 839 | $267.05 | $224k | Mar 27, 2026 |
| WILKINSON PETER JOfficer | Sell | 1.6k | $267.05 | $436k | Mar 27, 2026 |
| SCHROEDER MARK SChief Operating Officer | Grant | 12.3k | — | — | Mar 26, 2026 |
| SUMMY AMY BOfficer | Grant | 4.0k | — | — | Mar 26, 2026 |
| BAILEY MEGAN DOfficer | Grant | 1.2k | — | — | Mar 26, 2026 |
No analyst notes on LH yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 11 | 4 | 0 | 1 | Buy2.28 |
| 1 mo ago | 2 | 11 | 4 | 0 | 1 | Buy2.28 |
| 2 mo ago | 2 | 11 | 5 | 0 | 0 | Buy2.17 |
| 3 mo ago | 2 | 12 | 5 | 0 | 0 | Buy2.16 |